<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 標(biāo)準(zhǔn)樣品 >
    CH5424802-d8
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):C183362
    產(chǎn)品名稱:CH5424802-d8
    產(chǎn)品CAS:
    規(guī)格含量:10mg
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): C183362
    名稱: CH5424802-d8
    別名: 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzocarbazole-3-carbonitrile-d8
    參考CAS: 未標(biāo)記:1256580-46-7
    分子式: C??H??D?N?O?
    分子量: 490.67
    類別: Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: CH5424802-d8 is the labelled form of CH5424802 (C183360). CH5424802 is a highly selective and potent anaplastic lymphoma kinase (ALK) inhibitor capable of blocking the resistant gatekeeper mutant, which results in reduced cell growth. CH5424802 have been clinically evaluated for the treatment of patients with ALK-driven tumors.
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 @ 信陽(yáng)埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      一本—道久久a久久精品蜜桃 | 中国国产精品视频 | BBBBBBBBB成人免费毛片视频 | 亚洲激情网站 | 三级片麻豆|